<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
<journal-title>Frontiers in Molecular Biosciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Biosci.</abbrev-journal-title>
<issn pub-type="epub">2296-889X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1096261</article-id>
<article-id pub-id-type="doi">10.3389/fmolb.2023.1096261</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Biosciences</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Dual incorporation of non-canonical amino acids enables production of post-translationally modified selenoproteins</article-title>
<alt-title alt-title-type="left-running-head">Morosky et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmolb.2023.1096261">10.3389/fmolb.2023.1096261</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Morosky</surname>
<given-names>Pearl</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2115076/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Comyns</surname>
<given-names>Cody</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2096330/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nunes</surname>
<given-names>Lance G. A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chung</surname>
<given-names>Christina Z.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>Peter R.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/959463/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>S&#xf6;ll</surname>
<given-names>Dieter</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/148421/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vargas-Rodriguez</surname>
<given-names>Oscar</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1570805/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Krahn</surname>
<given-names>Natalie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1092842/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Molecular Biophysics and Biochemistry</institution>, <institution>Yale University</institution>, <addr-line>New Haven</addr-line>, <addr-line>CT</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Cell and Molecular Biology</institution>, <institution>John A. Burns School of Medicine</institution>, <institution>University of Hawaii</institution>, <addr-line>Honolulu</addr-line>, <addr-line>HI</addr-line>, <country>United States</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Chemistry</institution>, <institution>Yale University</institution>, <addr-line>New Haven</addr-line>, <addr-line>CT</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2064719/overview">Ned Budisa</ext-link>, University of Manitoba, Canada</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1292940/overview">Weimin Xuan</ext-link>, Tianjin University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1522636/overview">Xian Fu</ext-link>, Beijing Genomics Institute (BGI), China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/627173/overview">Chenguang Fan</ext-link>, University of Arkansas, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Natalie Krahn, <email>natalie.krahn@yale.edu</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Protein Biochemistry for Basic and Applied Sciences, a section of the journal Frontiers in Molecular Biosciences</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>01</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>10</volume>
<elocation-id>1096261</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>01</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Morosky, Comyns, Nunes, Chung, Hoffmann, S&#xf6;ll, Vargas-Rodriguez and Krahn.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Morosky, Comyns, Nunes, Chung, Hoffmann, S&#xf6;ll, Vargas-Rodriguez and Krahn</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Post-translational modifications (PTMs) can occur on almost all amino acids in eukaryotes as a key mechanism for regulating protein function. The ability to study the role of these modifications in various biological processes requires techniques to modify proteins site-specifically. One strategy for this is genetic code expansion (GCE) in bacteria. The low frequency of post-translational modifications in bacteria makes it a preferred host to study whether the presence of a post-translational modification influences a protein&#x2019;s function. Genetic code expansion employs orthogonal translation systems engineered to incorporate a modified amino acid at a designated protein position. Selenoproteins, proteins containing selenocysteine, are also known to be post-translationally modified. Selenoproteins have essential roles in oxidative stress, immune response, cell maintenance, and skeletal muscle regeneration. Their complicated biosynthesis mechanism has been a hurdle in our understanding of selenoprotein functions. As technologies for selenocysteine insertion have recently improved, we wanted to create a genetic system that would allow the study of post-translational modifications in selenoproteins. By combining genetic code expansion techniques and selenocysteine insertion technologies, we were able to recode stop codons for insertion of <italic>N</italic>
<sub>&#x3b5;</sub>-acetyl-<sc>l</sc>-lysine and selenocysteine, respectively, into multiple proteins. The specificity of these amino acids for their assigned position and the simplicity of reverting the modified amino acid <italic>via</italic> mutagenesis of the codon sequence demonstrates the capacity of this method to study selenoproteins and the role of their post-translational modifications. Moreover, the evidence that Sec insertion technology can be combined with genetic code expansion tools further expands the chemical biology applications.</p>
</abstract>
<kwd-group>
<kwd>selenoproteins</kwd>
<kwd>acetyl-lysine</kwd>
<kwd>post-translational modifications</kwd>
<kwd>genetic code expansion</kwd>
<kwd>selenocysteine</kwd>
<kwd>synthetic biology</kwd>
</kwd-group>
<contract-num rid="cn001">R35GM122560-05S1</contract-num>
<contract-num rid="cn002">5R01AI147496</contract-num>
<contract-num rid="cn003">DE-FG0298ER2031</contract-num>
<contract-sponsor id="cn001">National Institute of General Medical Sciences<named-content content-type="fundref-id">10.13039/100000057</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">National Institute of Allergy and Infectious Diseases<named-content content-type="fundref-id">10.13039/100000060</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">Basic Energy Sciences<named-content content-type="fundref-id">10.13039/100006151</named-content>
</contract-sponsor>
<contract-sponsor id="cn004">Natural Sciences and Engineering Research Council of Canada<named-content content-type="fundref-id">10.13039/501100000038</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Selenium is an essential micronutrient required for the biosynthesis of selenocysteine (Sec), which is exclusively found in selenoproteins. Selenoproteins are involved in many key cellular functions, including calcium and redox homeostasis, cell maintenance, and immune and inflammatory responses (<xref ref-type="bibr" rid="B32">Ye et al., 2022</xref>). Twenty-five selenoproteins have been identified in humans, but their functions remain poorly characterized. This is partly due to the complicated and highly regulated Sec biosynthesis and its insertion into proteins. In eukaryotes, this process depends on <italic>cis</italic> and <italic>trans-</italic>acting factors in the mRNA and transportation of the tRNA to the ribosome, respectively (<xref ref-type="bibr" rid="B20">Pinkerton and Copeland, 2016</xref>). Similar to bacterial systems, the Sec-charged tRNA (Sec-tRNA<sup>Sec</sup>) recognizes a dedicated UGA non-sense codon with the assistance of the Sec-specific elongation factor (eEFSec). Redefinition of the UGA codon as Sec is mediated by a hairpin element known as the Sec insertion sequence (SECIS) found up to 1,600 nucleotides away from the UGA codon in the 3&#x2032;-untranslated region (UTR) of eukaryotic selenoprotein mRNA. eEFSec brings Sec-tRNA<sup>Sec</sup> to the ribosome in response to the SECIS element in a process that involves an additional factor, the SECIS binding protein 2 (SBP2) (<xref ref-type="bibr" rid="B9">Copeland et al., 2000</xref>). SBP2 is predicted to bind to the SECIS element, bending the 3&#x2032;-UTR to interact with eEFSec, though the detailed mechanism is still not fully understood (<xref ref-type="bibr" rid="B13">Kossinova et al., 2014</xref>; <xref ref-type="bibr" rid="B12">Hilal et al., 2022</xref>).</p>
<p>The complicated translation path of eukaryotic selenoproteins poses a challenge to overexpress and purify these proteins for functional characterization studies. Some strategies [e.g., pSelExpress1, orthogonal aminoacyl-tRNA synthetase (aaRS):tRNA pairs] have been developed to address this challenge in eukaryotes [reviewed in (<xref ref-type="bibr" rid="B19">Novoselov et al., 2007</xref>; <xref ref-type="bibr" rid="B6">Chung and Krahn, 2022</xref>)]. However, the bacterial Sec insertion system is simpler, only requiring a specialized elongation factor (SelB) to recognize Sec-tRNA<sup>Sec</sup> and the SECIS element for insertion of Sec. As a result, more methodologies have been developed for recombinant Sec insertion in bacteria [reviewed in (<xref ref-type="bibr" rid="B6">Chung and Krahn, 2022</xref>)]. We have specifically focused on engineering SECIS-independent translation by removing the requirement for SelB and instead using the canonical elongation factor (EF-Tu) (<xref ref-type="bibr" rid="B1">Aldag et al., 2013</xref>). This method depends on allo-tRNAs, a tRNA species with an unusual cloverleaf structure (<xref ref-type="bibr" rid="B16">Mukai et al., 2017</xref>). We have since verified that some of the allo-tRNAs are recognized by EF-Tu (<xref ref-type="bibr" rid="B17">Mukai et al., 2018</xref>) with tertiary structures that facilitates accommodation in the <italic>E. coli</italic> ribosome (<xref ref-type="bibr" rid="B22">Prabhakar et al., 2022</xref>). Through engineering strategies, they have been altered for efficient Sec incorporation (<xref ref-type="bibr" rid="B17">Mukai et al., 2018</xref>).</p>
<p>As with standard protein expression, eukaryotic selenoproteins can also be expressed in bacteria but with minimal post-translational modifications (PTMs). To install PTMs into <italic>E. coli</italic> expressed proteins, genetic code expansion (GCE) utilizes orthogonal aaRS:tRNA synthetase pairs and non-canonical amino acids (ncAAs) (<xref ref-type="bibr" rid="B5">Chen et al., 2018</xref>; <xref ref-type="bibr" rid="B21">Porter and Mehl, 2018</xref>; <xref ref-type="bibr" rid="B31">Yang et al., 2018</xref>). The aaRS is engineered to accept diverse ncAAs typically for insertion at a non-sense or stop codon. Some commonly used orthogonal translation systems include the <italic>Methanocaldococcus jannaschii</italic> tyrosyl-tRNA synthetase (TyrRS) and archaeal pyrrolysyl-tRNA synthetase (PylRS) systems. The tolerance of PylRS to anticodon changes in its cognate tRNA<sup>Pyl</sup> makes it an attractive tool to recode any codon, while the codon choice for TyrRS can be more limiting due to its anticodon recognition (<xref ref-type="bibr" rid="B10">Crnkovi&#x107; et al., 2016</xref>). These systems have been used to insert common PTMs such as acetylation (<xref ref-type="bibr" rid="B14">Lacoursiere et al., 2020</xref>), phosphorylation (<xref ref-type="bibr" rid="B3">Balasuriya et al., 2020</xref>), or both (<xref ref-type="bibr" rid="B28">Venkat et al., 2018</xref>).</p>
<p>The presence of three non-sense codons in the genetic code offers an opportunity to insert multiple ncAAs into a single protein by combining existing orthogonal systems. To this end, several studies have demonstrated the synthesis of proteins containing two and even three ncAAs (<xref ref-type="bibr" rid="B18">Neumann et al., 2010</xref>; <xref ref-type="bibr" rid="B4">Chatterjee et al., 2013</xref>; <xref ref-type="bibr" rid="B29">Wang et al., 2014</xref>; <xref ref-type="bibr" rid="B11">Dunkelmann et al., 2020</xref>; <xref ref-type="bibr" rid="B27">Tharp et al., 2021</xref>). Since tRNA<sup>Sec</sup> is acylated with Ser by endogenous seryl-tRNA synthetase (SerRS) before conversion to Sec <italic>via</italic> dedicated enzymes, it may be compatible with many of these orthogonal translation systems. This was tested with the natural Sec machinery in <italic>E. coli</italic>. Using a natural eukaryotic selenoprotein with a penultimate Sec amino acid, mRNA engineering facilitated a SECIS element to be inserted into the 3&#x2032;-UTR of the mRNA while still promoting recognition by endogenous SelB for Sec insertion. Combining this with AcKRS (an aaRS evolved from <italic>Methanosarcinae</italic> PylRS) for incorporation of <italic>N</italic>
<sub>&#x3b5;</sub>-acetyl-<sc>l</sc>-lysine (AcK) showed the compatibility of these two systems and their capability of introducing AcK into a natural selenoprotein (<xref ref-type="bibr" rid="B30">Wright et al., 2018</xref>). However, the requirement of a SECIS element immediately downstream of the UGA codon limits this strategy to natural bacterial selenoproteins or eukaryotic selenoproteins with a Sec residue at the C-terminal end (penultimate or ultimate state).</p>
<p>Here we present a new strategy for the simultaneous insertion of Sec and AcK into super-folder green fluorescent protein (sfGFP) and human glutathione peroxidase 1 (GPx1). We achieved this by combining a previously engineered Sec-incorporation system to site-specifically insert Sec anywhere in a polypeptide chain (<xref ref-type="bibr" rid="B17">Mukai et al., 2018</xref>) with a <italic>M. alvus</italic> PylRS engineered for insertion of AcK (<xref ref-type="fig" rid="F1">Figure 1</xref>) (<xref ref-type="bibr" rid="B24">Seki et al., 2020</xref>). With the correct choice of anticodon for each of these translation systems, we facilitated increased codon orthogonality and suppression to yield post-translationally modified selenoproteins. This further expands the genetic code expansion toolbox, enabling the capability to design novel proteins and study eukaryotic selenoproteins in <italic>E. coli</italic>.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Schematic of dual ncAA incorporation to produce post-translationally modified seleno-sfGFP. <bold>(A)</bold> Endogenous <italic>E. coli</italic> seryl-tRNA synthetase (SerRS represented by PDB:1SER) aminoacylates allo-tRNA<sup>UTu1D</sup> with <sc>l</sc>-serine, which is then converted to <sc>l</sc>-Sec by <italic>A. salmonicida</italic> selenocysteine synthase (SelA represented by PDB:3W1K). <italic>M. alvus</italic> PylRS containing mutations for recognition of <italic>N</italic>
<sub>&#x3b5;</sub>-acetyl-<sc>l</sc>-lysine (AcK) (<italic>Ma</italic>AcKRS3-IP represented by PDB:4Q6G) aminoacylates <italic>M. alvus</italic> tRNA<sup>Pyl</sup>. <bold>(B)</bold> Aminoacylated allo-tRNA<sup>UTu1D</sup> and tRNA<sup>Pyl</sup> insert Sec and AcK, respectively, at specific positions in the mRNA. These tRNAs are encoded to suppress stop codons (UAG or UGA), leading to the biosynthesis of AcK-seleno-sfGFP (represented by PDB:1EMB).</p>
</caption>
<graphic xlink:href="fmolb-10-1096261-g001.tif"/>
</fig>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 General</title>
<p>Enzymes for molecular cloning were purchased from New England Biolabs and Takara Bio. Gene fragments were purchased from Integrated DNA Technologies and Twist Bioscience. W.M. Keck Foundation at Yale University provided oligonucleotide synthesis (<xref ref-type="sec" rid="s10">Supplementary Table S1</xref>) and DNA plasmid (<xref ref-type="sec" rid="s10">Supplementary Table S2</xref>) sequencing. Antibiotics and media additives were used at the following final concentrations: ampicillin (amp), 100&#xa0;&#x3bc;g/mL; spectinomycin (spec), 50&#xa0;&#x3bc;g/mL; glucose, 1% (w/v); arabinose, 0.1% (w/v); sodium selenite, 10&#xa0;&#x3bc;M; <italic>N</italic>
<sub>&#x3b5;</sub>-acetyl-<sc>l</sc>-lysine (AcK), 10&#xa0;mM; nicotinamide, 20&#xa0;mM.</p>
</sec>
<sec id="s2-2">
<title>2.2 Plasmid construction</title>
<sec id="s2-2-1">
<title>2.2.1 pB_sfGFP_2TGA (pB_PM02) and pB_sfGFP_151TAG (pB_PM03)</title>
<p>The stop codon of the sfGFP gene in the previously reported pB_sfGFP plasmid (<xref ref-type="bibr" rid="B8">Chung et al., 2022</xref>) was mutated to TAA using the primer pair PM01/02 (pB_PM01). PM03/04 and PM05/06 primers were used separately to introduce a TGA at position 2 (2TGA) or a TAG at position 151 (151TAG) of sfGFP in the pB_PM01 plasmid. This provided the plasmids (pB_PM02 and pB_PM03) to test each suppression system individually.</p>
</sec>
<sec id="s2-2-2">
<title>2.2.2 pB_sfGFP_2TGA-<italic>Ma</italic>AcLysRS3-tRNA<sup>Pyl</sup>
<sub>UCA</sub> (pB_PM06) and pB_sfGFP_151TAG-<italic>Ma</italic>AcLysRS3- tRNA<sup>Pyl</sup>
<sub>UCA</sub> (pB_PM07)</title>
<p>To insert the PylRS and tRNA<sup>Pyl</sup> genes for AcK insertion into the previously designed plasmids, the primer pair PM07/08 was used to amplify the chemically synthesized <italic>Ma</italic>AcLysRS3-IP gene (<xref ref-type="bibr" rid="B24">Seki et al., 2020</xref>) and insert a proK promoter. Primers PM09/10 opened the pB_PM01, pB_PM02 or pB_PM03 plasmids downstream of the origin of replication with overhangs complementary to the amplified <italic>Ma</italic>AcLysRS3-IP fragment to insert in the reverse direction. The opened pB_PM01, pB_PM02 or pB_PM03 and <italic>Ma</italic>AcLysRS3-IP fragment were assembled with NEBuilder HiFi to generate pB_PM04, pB_PM05, and pB_PM06, respectively. These plasmids were then opened upstream of <italic>Ma</italic>AcLysRS3-IP with PM11/12 to insert the <italic>M. alvus</italic> tRNA<sup>Pyl</sup>
<sub>UCA</sub> fragment containing an Lpp promoter and rrcn terminator. The tRNA<sup>Pyl</sup>
<sub>UCA</sub> fragment was amplified with PM13/14 from a pBAD-sfGFP-tRNA plasmid (<xref ref-type="bibr" rid="B26">Tharp et al., 2020</xref>) containing the sequence for tRNA<sup>Pyl</sup>
<sub>UCA</sub>. The opened pB_PM04, pB_PM05, and pB_PM06 plasmids and tRNA<sup>Pyl</sup>
<sub>UCA</sub> fragment were assembled with NEBuilder HiFi to generate pB_PM07, pB_PM08, and pB_PM09, respectively.</p>
</sec>
<sec id="s2-2-3">
<title>2.2.3 pB_sfGFP_2TGA_151TAG-<italic>Ma</italic>AcLysRS3- tRNA<sup>Pyl</sup>
<sub>UCA</sub> (pB_PM10)</title>
<p>Starting with the pB_PM08 plasmid, PM05/06 primers were used to add the second stop codon within the coding region of sfGFP for dual suppression studies.</p>
</sec>
<sec id="s2-2-4">
<title>2.2.4 pB_04_2TGA-<italic>Ma</italic>AcLysRS3- tRNA<sup>Pyl</sup>
<sub>UCA</sub> (pB_PM13)</title>
<p>The pB_04 plasmid containing sfGFP disrupted by the M86 DnaB mini-intein at position 204 was previously used to detect Sec insertion (<xref ref-type="bibr" rid="B8">Chung et al., 2022</xref>). The primer pair PM01/02 was used first to mutate the stop codon to TAA (pB_PM11). Due to the presence of a TAG already in the intein-sfGFP fusion, the second in-frame stop codon, TGA, was inserted at position 2 using the PM03/04 primers (pB_PM12). Insertion of the AcK-translation system (<italic>Ma</italic>AcLysRS3-mA17) was achieved as described in <xref ref-type="sec" rid="s2-2-2">Section 2.2.2</xref> (pB_PM13).</p>
</sec>
<sec id="s2-2-5">
<title>2.2.5 pB_sfGFP-<italic>Ma</italic>AcLysRS3-tRNA<sup>Pyl</sup>
<sub>CUA</sub> plasmids (pB_PM14, pB_PM15, pB_PM16, and pB_PM17)</title>
<p>The anticodon sequence of the tRNA<sup>Pyl</sup>
<sub>UCA</sub> gene in plasmids pB_PM07, pB_PM08, pB_PM09, and pB_PM10 plasmids was mutated to CUA to suppress the UAG codon using the primer pair PM15/16. This generated plasmids pB_PM14, pB_PM15, pB_PM16, and pB_PM17, respectively.</p>
</sec>
<sec id="s2-2-6">
<title>2.2.6 pB_04TGA_2TAG-<italic>Ma</italic>AcLysRS3-tRNA<sup>Pyl</sup>
<sub>CUA</sub> (pB_PM18)</title>
<p>The anticodon sequence of tRNA<sup>Pyl</sup>
<sub>UCA</sub> from pB_PM13 was also converted to CUA following the strategy described in 2.2.5. However, since the intein is specific for Sec insertion, the codons at position 2 of sfGFP and position 204 (position 1 of the intein) had to also be switched. Primer pairs PM17/18 and PM19/20 were used to convert 2TGA to 2TAG and pB_04 to pB_04TGA, respectively.</p>
</sec>
<sec id="s2-2-7">
<title>2.2.7 pSecUGA</title>
<p>To recode UGA with Sec, the anticodon of allo-tRNA<sup>UTu1D</sup> in the pSecUAG plasmid (<xref ref-type="bibr" rid="B17">Mukai et al., 2018</xref>; <xref ref-type="bibr" rid="B7">Chung et al., 2021</xref>) was changed to UCA. This was done using primer pair PM21/22 on the pSecUAG plasmid to generate pSecUGA.</p>
</sec>
<sec id="s2-2-8">
<title>2.2.8 pB_GPx1_49TAG<italic>-Ma</italic>AcLysRS3-tRNA<sup>Pyl</sup>
<sub>CUA</sub> (pB_PM19)</title>
<p>For GPx1 expression, the human GPx1 gene was inserted into the pB<italic>-Ma</italic>AcLysRS3-tRNA<sup>Pyl</sup>
<sub>CUA</sub> vector containing genes for AcK insertion at UAG. Primer pair PM23/24 amplified GPx1_49TAG from pET-GPx1 (<xref ref-type="bibr" rid="B17">Mukai et al., 2018</xref>), while primer pair PM25/26 was used to open pB_PM17. Digestion with DpnI removed any parental plasmid from the PCR product before NEBuilder HiFi assembled the two PCR purified samples (Gpx1_49TAG and pB-<italic>Ma</italic>AcLysRS3-tRNA<sup>Pyl</sup>
<sub>CUA</sub>). This produced plasmid pB_PM19.</p>
</sec>
<sec id="s2-2-9">
<title>2.2.9 pB_GPx1_49TGA_114TAG<italic>-Ma</italic>AcLysRS3-tRNA<sup>Pyl</sup>
<sub>CUA</sub> (pB_PM21) and pB_GPx1_49TGA_148TAG-<italic>Ma</italic>AcLysRS3-tRNA<sup>Pyl</sup>
<sub>CUA</sub> plasmids (pB_PM22)</title>
<p>Mutagenesis of position 49 to encode a UGA was accomplished with primer pair PM27/28 on pB_PM19. This resulting plasmid (pB_PM20) was then subject to further mutagenesis to install UAG codons at position 114 or 148 (using primer pairs PM29/30 or PM31/32, respectively) for insertion of AcK. Final plasmids (pB_PM21 and pB_PM22) were then ready for dual insertion of Sec and AcK.</p>
</sec>
</sec>
<sec id="s2-3">
<title>2.3 sfGFP fluorescence assay</title>
<p>Plasmids were transformed into electrocompetent <italic>E. coli</italic> cells (B-95.&#x394;A.&#x394;<italic>fabR</italic>&#x394;<italic>selABC</italic>) (<xref ref-type="bibr" rid="B15">Mukai et al., 2015</xref>) and plated on Luria Broth (LB) agar containing appropriate antibiotics and incubated overnight at 37&#xb0;C. Single colonies were grown in 150&#xa0;&#x3bc;L media at 37&#xb0;C for 6&#xa0;h in a 96-well black plate with clear bottoms. Unless otherwise noted, the media containing appropriate antibiotics included glucose, arabinose, sodium selenite, AcK, and nicotinamide was used. After 6&#xa0;h, 75&#xa0;&#x3bc;L from each well was transferred to a clean well in the same plate. The original wells were replenished with 75&#xa0;&#x3bc;L of fresh media, while protein expression was induced in the new wells by adding 75&#xa0;&#x3bc;L of media containing 2&#xa0;mM isopropyl &#x3b2;-d-1-thiogalactopyranoside (IPTG). Fluorescent measurements and analysis were performed as described previously (<xref ref-type="bibr" rid="B8">Chung et al., 2022</xref>) using a minimum of four biological replicates.</p>
</sec>
<sec id="s2-4">
<title>2.4 Post-translationally modified selenoprotein production</title>
<p>For protein expression, pB_PM17, pB_PM21, or pB_PM22 plasmids were co-transformed with pSecUGA into electrocompetent <italic>E. coli</italic> cells (B-95.&#x394;A.&#x394;<italic>fabR</italic>&#x394;<italic>selABC</italic>) (<xref ref-type="bibr" rid="B15">Mukai et al., 2015</xref>) before plated on LB agar containing appropriate antibiotics and incubated overnight at 37&#xb0;C. Single colonies were grown overnight at 37&#xb0;C in 25&#xa0;mL LB containing the appropriate antibiotics. Precultures were transferred to 1&#xa0;L of LB containing antibiotics, arabinose, and sodium selenite and grown at 37&#xb0;C. At an OD<sub>600</sub> &#x3d; 0.6, protein expression was induced with 0.5&#xa0;mM IPTG, following the addition of nicotinamide, AcK, and extra sodium selenite. Proteins were expressed at 20&#xb0;C for 16&#xa0;h before pelleting the cells for purification.</p>
<p>All purification steps were performed under anaerobic conditions (90% N<sub>2</sub>, 5% H<sub>2</sub>, 5% CO<sub>2</sub>) in an anaerobic tent (Coy Laboratories). Each cell pellet was resuspended in 18&#xa0;mL lysis buffer (50&#xa0;mM sodium phosphate [pH 8.0], 300&#xa0;mM NaCl, 30&#xa0;mM imidazole, 10% (v/v) glycerol, 120&#xa0;&#x3bc;g/mL lysozyme, 30&#xa0;&#x3bc;g/mL Dnase, 0.5&#xa0;mM phenylmethylsulfonyl fluoride [PMSF]) and 2&#xa0;mL BugBuster<sup>&#xae;</sup> 10 X Extraction Reagent (EMD Millipore). The lysed cells were incubated at room temperature for 20&#xa0;min before the lysate was ultracentrifuged at 45,000&#xa0;rpm (150,000 x g) for 45&#xa0;min at 4&#xb0;C. The supernatant was 0.45&#xa0;&#x3bc;m filtered before being loaded onto a 1&#xa0;mL Ni-NTA column pre-equilibrated with wash buffer (50&#xa0;mM sodium phosphate [pH 8.0], 300&#xa0;mM NaCl, 30&#xa0;mM imidazole, 10% (v/v) glycerol). The beads were washed with 50&#xa0;mL of wash buffer and then eluted in 1&#xa0;mL fractions with elution buffer (50&#xa0;mM sodium phosphate [pH 8.0], 300&#xa0;mM NaCl, 250&#xa0;mM imidazole, 10% (v/v) glycerol). Protein fractions were combined, concentrated, and buffer exchanged into storage buffer (50&#xa0;mM sodium phosphate [pH 8.0], 300&#xa0;mM NaCl, 10% (v/v) glycerol) before being stored at &#x2212;80&#xb0;C.</p>
</sec>
<sec id="s2-5">
<title>2.5 Mass spectrometry analysis</title>
<p>LC-MS analysis of dithiothreitol reduced samples were performed on a ThermoFisher Scientific Orbitrap Exploris 240 mass spectrometer, equipped with a heated electrospray ionization source (H-ESI) in positive ion mode with a ThermoFisher Ultimate 3000 RSLCnano HPLC System. On H-ESI source, sheath gas was set to 2 arbitrary units (arb), and auxiliary gas was set to 6 arb. The ion transfer tube was set at 275&#xb0;C and the vaporizer temp at 200&#xb0;C. The sample was analyzed on a MAbPac RP, 4&#xa0;&#x3bc;M, 3.0&#xa0;mm &#xd7; 50&#xa0;mm analytical column (ThermoFisher Scientific), held at 60&#xb0;C. The protein was eluted at a rate of 500&#xa0;&#x3bc;L/min for a 10-min gradient, where 0&#x2013;7&#xa0;min: 10%&#x2013;70% acetonitrile &#x2b; 0.1% formic acid; 7&#x2013;8.2&#xa0;min: 95% acetonitrile &#x2b; 0.1% formic acid, 8.2&#x2013;10&#xa0;min: 20% acetonitrile &#x2b; 0.1% formic acid. MS spectra were acquired using full scans at 15,000 resolution in the orbitrap within a range of 700&#x2013;2,200&#xa0;m/z. The maximum injection time was set at auto with a standard AGC target. Ten micro scans were employed, and the RF lens was set to 100%. 15&#xa0;V of insource CID was applied. Thermo BioPharma Finder 5.1 was used for intact mass deconvolution and peak identification.</p>
</sec>
<sec id="s2-6">
<title>2.6 Western blot to identify acetylation</title>
<p>Approximately 5&#xa0;&#x3bc;g of GPx1 protein samples were loaded onto a 4%&#x2013;20% Mini-PROTEAN TGX stain-free gel (Bio-Rad) in reducing conditions. Samples were transferred to nitrocellulose and acetylation was detected with a primary mouse anti-acetylated lysine mAb (Novus Biologicals) and secondary anti-mouse IgG HRP-linked antibody (Cell Signaling Technology).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Determination of suppression codon choice</title>
<p>Using our established pSecUAG plasmid system for insertion of Sec at UAG codons, we first engineered the anticodon of <italic>M. alvus</italic> tRNA<sup>Pyl</sup> to recode UGA codons (tRNA<sup>Pyl</sup>
<sub>UCA</sub>). Before testing the orthogonality of each tRNA for its respective codon, we confirmed the specificity of <italic>Ma</italic>AcLysRS3-IP for AcK (<xref ref-type="bibr" rid="B24">Seki et al., 2020</xref>). <italic>E. coli</italic> cells expressing only pB_PM08 showed significantly higher fluorescence (<italic>p</italic> &#x3c; 0.0001) in the presence of AcK compared to cells without the amino acid (<xref ref-type="fig" rid="F2">Figure 2A</xref>). This suggests that AcK promotes readthrough of the UGA codon in sfGFP with the <italic>Ma</italic>AcLysRS3:tRNA<sup>Pyl</sup>
<sub>UCA</sub> pair.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Fluorescence assay observes bias for UAG suppression. <bold>(A)</bold> To first test the specificity of the <italic>Ma</italic>AcKRS system for the presence of <italic>N</italic>
<sub>&#x3b5;</sub>-acetyl-<sc>l</sc>-lysine (AcK), pB_PM06 was used. This plasmid contains sfGFP under the control of a T7 promoter encoding a UGA at position 2 (2UGA), <italic>Ma</italic>AcKRS3-IP under a proK promoter, and tRNA<sup>Pyl</sup>
<sub>UCA</sub> (<italic>pylT</italic>) under an Lpp promoter. The presence of AcK promoted sfGFP fluorescence (<italic>p</italic> &#x3c; 0.0001, <italic>n</italic> &#x3d; 4). <bold>(B)</bold> pB_PM06 and pB_PM07 plasmids encoding 2UGA or 151UAG, respectively, were tested for the specificity of tRNA<sup>Pyl</sup>
<sub>UCA</sub> for its cognate codon (UGA). Significant increase in readthrough fluorescence (<italic>p</italic> &#x3c; 0.0001, <italic>n</italic> &#x3d; 4) was observed for 151UAG, the non-cognate codon. <bold>(C)</bold> Combining plasmids pB_PM02 or pB_PM03 encoding 2UGA or 151UAG, respectively, and pSecUAG allowed a test for UAG suppression by allo-tRNA<sup>UTu1D</sup>
<sub>CUA</sub>. This plasmid contains the machinery for insertion of Sec, namely allo-tRNA<sup>UTu1D</sup>
<sub>CUA</sub> (UTu1D) under the araBAD promoter and <italic>A. salmonicida</italic> (<italic>As</italic>) SelA under EM7. Similar readthrough fluorescence was observed for both codons with a preference for its cognate codon, UAG (<italic>p</italic> &#x3c; 0.01, <italic>n</italic> &#x3d; 4). <bold>(D)</bold> Combining this information, tRNA<sup>Pyl</sup>
<sub>UCA</sub> (green) poorly suppresses its cognate codon UGA but is much better at suppressing UAG, while allo-tRNA<sup>UTu1D</sup>
<sub>CUA</sub> (magenta) also suppresses both codons with a bias towards UAG. Increase in suppression efficiency is denoted by an increase in &#x2b; and bolder arrow.</p>
</caption>
<graphic xlink:href="fmolb-10-1096261-g002.tif"/>
</fig>
<p>When using multiple translation systems to suppress more than one stop codon, confirming the codon specificity and orthogonality of engineered suppressor tRNAs is imperative. Therefore, we tested the ability of each system to readthrough UAG or UGA independently. To first investigate the ability of tRNA<sup>Pyl</sup>
<sub>UCA</sub> to specifically suppress UGA, we expressed the plasmid pB_PM08 or pB_PM09 in the presence of AcK. Notably, a significant increase (<italic>p</italic> &#x3c; 0.0001) in GFP fluorescence for readthrough of 151UAG relative to 2UGA was observed (<xref ref-type="fig" rid="F2">Figure 2B</xref>), suggesting that tRNA<sup>Pyl</sup>
<sub>UCA</sub> has a propensity to decode UAG codons better than its cognate UGA codon. We also tested this for allo-tRNA<sup>UTu1D</sup>
<sub>CUA</sub> by expressing plasmids pB_PM02 or pB_PM03 together with pSecUAG in the presence of sodium selenite. Interestingly, allo-tRNA<sup>UTu1D</sup>
<sub>CUA</sub> translated both 2UGA and 151UAG, with a significant increase in fluorescence (<italic>p</italic> &#x3c; 0.01) observed for the intended UAG codon (<xref ref-type="fig" rid="F2">Figure 2C</xref>). Together, these results show that tRNA<sup>Pyl</sup>
<sub>UCA</sub> and allo-tRNA<sup>UTu1D</sup>
<sub>CUA</sub> can suppress both UGA and UAG codons in isolation, displaying a higher efficiency to recode UAG (<xref ref-type="fig" rid="F2">Figure 2D</xref>). The propensity to recode UAG was also observed when testing the suppression efficiency of each codon individually (pB_PM08 or pB_PM09) and together (pB_PM10) compared to wild-type (pB_PM07) in the presence of AcK and sodium selenite (<xref ref-type="sec" rid="s10">Supplementary Figure S1A</xref>). Thus, these two tRNA variants are not entirely orthogonal.</p>
<p>To test whether codon specificity can be attained, we swapped the anticodons of both tRNAs, resulting in tRNA<sup>Pyl</sup>
<sub>CUA</sub> and allo-tRNA<sup>UTu1D</sup>
<sub>UCA</sub>. This led to the pB series (pB_PM14, pB_PM15, pB_PM16, and pB_PM17) and pSecUGA to decode UAG and UGA, respectively. We again confirmed that the <italic>Ma</italic>AcLysRS3:tRNA<sup>Pyl</sup>
<sub>CUA</sub> pair relies on AcK for efficient readthrough (<italic>p</italic> &#x3c; 0.01) (<xref ref-type="fig" rid="F3">Figure 3A</xref>). Importantly, we found that tRNA<sup>Pyl</sup>
<sub>CUA</sub> almost exclusively translates the UAG codon, with minimal decoding of UGA. Expressing only pB_PM15 or pB_PM16 we observed fluorescence when 151UAG is present but not in the presence of 2UGA (<italic>p</italic> &#x3c; 0.0001) (<xref ref-type="fig" rid="F3">Figure 3B</xref>). Similarly, allo-tRNA<sup>UTu1D</sup>
<sub>UCA</sub> displayed a higher specificity for UGA than UAG. Expressing pSecUGA with pB_PM02 or pB_PM03, we observed the opposite, fluorescence with 2UGA and not 151UAG (<italic>p</italic> &#x3c; 0.0001) (<xref ref-type="fig" rid="F3">Figure 3C</xref>). Furthermore, the suppression efficiencies of each codon individually (pB_PM15 or pB_PM16) and together (pB_PM17) were comparable and roughly 60%&#x2013;70% of wild-type sfGFP (pB_PM14) in the presence of AcK and sodium selenite (<xref ref-type="sec" rid="s10">Supplementary Figure S1B</xref>). These data suggest that allo-tRNA<sup>UTu1D</sup>
<sub>UCA</sub> and tRNA<sup>Pyl</sup>
<sub>CUA</sub> can simultaneously insert AcK at UAG and Sec at UGA into proteins efficiently (<xref ref-type="fig" rid="F3">Figure 3D</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Anticodon swap creates codon orthogonality. <bold>(A)</bold> <italic>N</italic>
<sub>&#x3b5;</sub>-acetyl-<sc>l</sc>-lysine (AcK) was still found to be required for significant fluorescence (<italic>p</italic> &#x3c; 0.0001, <italic>n</italic> &#x3d; 4) of sfGFP with plasmid pB_PM13. This plasmid contains sfGFP under the control of a T7 promoter encoding a UAG at position 151 (151UAG), <italic>Ma</italic>AcKRS3-IP under a proK promoter, and tRNA<sup>Pyl</sup>
<sub>CUA</sub> (<italic>pylT</italic>) under an Lpp promoter. <bold>(B)</bold> pB_PM12 and pB_PM13 encoding 2UGA or 151UAG, respectively, were tested for the specificity of tRNA<sup>Pyl</sup>
<sub>CUA</sub> for its cognate codon (UAG). Significant increase in readthrough fluorescence (<italic>p</italic> &#x3c; 0.0001, <italic>n</italic> &#x3d; 4) was observed for 151UAG, the cognate codon, compared to 2UGA. <bold>(C)</bold> Combining plasmids pB_PM02 or pB_PM03 encoding 2UGA or 151UAG, respectively, and pSecUGA allowed a test for UGA suppression by allo-tRNA<sup>UTu1D</sup>
<sub>UCA</sub>. This plasmid contains the machinery for insertion of Sec, namely allo-tRNA<sup>UTu1D</sup>
<sub>UCA</sub> (UTu1D) under the araBAD promoter and <italic>Aeromonas salmonicida</italic> (<italic>As</italic>) SelA under EM7. Significant increase in readthrough fluorescence (<italic>p</italic> &#x3c; 0.0001, <italic>n</italic> &#x3d; 4) was observed for 2UGA, the cognate codon, compared to 151UAG. <bold>(D)</bold> Combining this information, allo-tRNA<sup>UTu1D</sup>
<sub>UCA</sub> (magenta) is efficient at UGA suppression, while tRNA<sup>Pyl</sup>
<sub>CUA</sub> (green) is efficient at UAG suppression, creating an orthogonal system for dual suppression. Increase in suppression efficiency is denoted by an increase in &#x2b; and bolder arrow. Grey arrows denote that no suppression was observed.</p>
</caption>
<graphic xlink:href="fmolb-10-1096261-g003.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 Dual insertion of AcK and Sec in a fluorescent reporter</title>
<p>Next, we combined the AcK and Sec incorporation systems to produce a synthetic post-translationally modified selenoprotein (AcK-seleno-sfGFP). We first tested the activities of the <italic>Ma</italic>AcLysRS3:tRNA<sup>Pyl</sup>
<sub>CUA</sub> and the Sec-translation systems (<xref ref-type="fig" rid="F4">Figure 4A</xref>) in the presence and absence of AcK and arabinose (for allo-tRNA<sup>UTu1D</sup>
<sub>UCA</sub> expression). Significant sfGFP fluorescence (<italic>p</italic> &#x3c; 0.001) was only observed in the presence of both AcK and arabinose but not if one or both is missing (<xref ref-type="fig" rid="F4">Figure 4B</xref>), confirming the feasibility and compatibility of these two systems. Due to the possibility of Ser misincorporation by the pSecUGA system, we confirmed Sec incorporation using pB_PM18 (<xref ref-type="fig" rid="F5">Figure 5A</xref>) which was engineered based on our previously developed Sec-specific sfGFP reporter (pB_04) (<xref ref-type="bibr" rid="B8">Chung et al., 2022</xref>). The sfGFP reporter is only functional (fluorescent) when Sec is inserted at amino acid 204 (position 1 of the M86 mini intein) to facilitate cleavage and splicing of the two sfGFP fragments (<xref ref-type="bibr" rid="B2">Appleby-Tagoe et al., 2011</xref>). Moreover, mutagenesis of codon 2 to UAG and the stop codon of the sfGFP to UAA allows for simultaneously monitoring the insertion of two ncAAs. By monitoring the fluorescence of the intein-sfGFP reporter, we only observed significant activity when both suppression systems and sodium selenite (<xref ref-type="fig" rid="F5">Figure 5B</xref>) were present. These results corroborate that the fluorescence observed with the pB_PM17 plasmid (<xref ref-type="fig" rid="F4">Figure 4B</xref>) is due to the presence of Sec. Moreover, the lack of fluorescence in the absence of AcK verifies its requirement and insertion at UAG (<xref ref-type="fig" rid="F3">Figures 3A</xref>, <xref ref-type="fig" rid="F4">4B</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Fluorescence from dual suppression in sfGFP. <bold>(A)</bold> The assay was performed with a two-plasmid system: pB_PM14 and pSecUGA. The first plasmid contains the genes for <italic>Ma</italic>AcKRS3-IP and tRNA<sup>Pyl</sup>
<sub>CUA</sub> (<italic>pylT</italic>) for insertion of <italic>N</italic>
<sub>&#x3b5;</sub>-acetyl-<sc>l</sc>-lysine (AcK) at a UAG and pSecUGA contains the machinery for insertion of Sec at a UGA. In the presence of AcK, arabinose, and sodium selenite, the entire sfGFP gene should be expressed to produce fluorescence. In the absence of AcK or arabinose (or both), translation stops resulting in truncated non-fluorescent protein. Without arabinose, only the first amino acid would be translated. Without AcK, translation would continue until the UAG at position 151 to produce a truncated protein. <bold>(B)</bold> sfGFP assay shows successful readthrough of both codons in the presence of AcK and Sec with a significant increase in fluorescence (<italic>p</italic> &#x3c; 0.001) compared to when only one or none of the components were added. Data are shown as the average of at least four biological replicates with the corresponding standard deviation shown with error bars.</p>
</caption>
<graphic xlink:href="fmolb-10-1096261-g004.tif"/>
</fig>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Confirmation of Sec insertion using intein reporter. <bold>(A)</bold> The assay was performed with a two-plasmid system: pB_PM15 and pSecUGA. The first plasmid contains the genes for <italic>Ma</italic>AcKRS3-IP and tRNA<sup>Pyl</sup>
<sub>CUA</sub> (<italic>pylT</italic>) for insertion of <italic>N</italic>
<sub>&#x3b5;</sub>-acetyl-<sc>l</sc>-lysine (AcK) at a UAG and a modified pB_04 sfGFP intein reporter gene. This gene has been modified from the original (<xref ref-type="bibr" rid="B8">Chung et al., 2022</xref>) to encode a UAG at position 2 and a UGA at position 204, the first position of the M86 mini-intein. The second plasmid, pSecUGA, contains machinery for Sec insertion at UGA. In the presence of AcK, arabinose, and sodium selenite, the entire sfGFP gene should be expressed. When Sec is inserted at position 204, the intein will splice out to produce a fluorescent functional reporter. In the absence of sodium selenite alone, the entire sfGFP gene should be expressed except serine (Ser) should be inserted at position 204, which does not induce splicing. This results in a non-functional, non-fluorescent protein. In the absence of AcK or arabinose (or both), translation stops resulting in truncated non-fluorescent protein. Only the first amino acid would be translated without AcK, while without arabinose, translation would stop at 204UGA. <bold>(B)</bold> The sfGFP_intein assay shows successful readthrough of position 2 and splicing of the intein in the presence of AcK, arabinose, and sodium selenite, with a significant increase in fluorescence (<italic>p</italic> &#x3c; 0.0001) compared to when any one of the components is missing or in the absence of them all. Data are shown as the average of at least four biological replicates with the corresponding standard deviation shown with error bars.</p>
</caption>
<graphic xlink:href="fmolb-10-1096261-g005.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 Expression of post-translationally modified seleno-sfGFP in <italic>E. coli</italic>
</title>
<p>The sfGFP readthrough and intein assays demonstrated that AcK and Sec could be inserted into a single protein using two different stop codons. Therefore, we applied our integrated plasmid setup and growth conditions to express and purify acetylated seleno-sfGFP from <italic>E. coli</italic>. The location of the His<sub>6</sub>-tag on the C-terminus allowed the separation of full-length protein from truncated versions due to early termination (<xref ref-type="fig" rid="F5">Figure 5A</xref>). This strategy produced a robust band at roughly 25&#xa0;kDa correlating to our expected protein size (28&#xa0;kDa) (<xref ref-type="fig" rid="F6">Figure 6</xref>). We also compared our optimized system, which involves recoding UGA with Sec and UAG with AcK, to our original system (recoding UGA with AcK and UAG with Sec) (<xref ref-type="fig" rid="F6">Figure 6A</xref>). In both systems, we obtained pure protein; however, our yields were increased roughly 5-fold with our optimized codon set compared to the original (<xref ref-type="fig" rid="F6">Figure 6B</xref>). Mass spectrometry analysis of the optimized codon set confirmed the presence of acetylated seleno-sfGFP. Protein mass was also detected that corresponded to Gln instead of AcK at a proportion of 67%, suggesting that near-cognate suppression by tRNA<sup>Gln</sup> can impact the final protein purity (<xref ref-type="fig" rid="F6">Figure 6C</xref>). This was further verified with MS/MS data to show that indeed AcK or Gln was inserted at position 151 while Sec was always observed at position 2 (<xref ref-type="sec" rid="s10">Supplementary Figure S2</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Production of AcK-seleno-sfGFP. <bold>(A)</bold> Schematic of tRNAs used and the respective codons they are expected to recode. Optimized conditions involved Sec insertion at position 2UGA with allo-tRNA<sup>UTu1D</sup>
<sub>UCA</sub> and <italic>N</italic>
<sub>&#x3b5;</sub>-acetyl-<sc>l</sc>-lysine (AcK) at 151UAG with tRNA<sup>Pyl</sup>
<sub>CUA</sub>. Original conditions involved AcK insertion at position 2UGA with tRNA<sup>Pyl</sup>
<sub>UCA</sub> and Sec insertion at 151UAG with allo-tRNA<sup>UTu1D</sup>
<sub>CUA</sub>. An increase in the amount of &#x2b; signs correspond to the increased suppression observed. <bold>(B)</bold> SDS-PAGE shows a strong band around the 25&#xa0;kDa marker, corresponding to the AcK-seleno-sfGFP size of 28&#xa0;kDa. An increase in protein yield was found for the anticodon-optimized conditions compared to the original. <bold>(C)</bold> Intact MS data has multiple peaks which can be assigned to AcK-seleno-sfGFP (37%) and Gln-seleno-sfGFP (63%) with or without an oxidation state.</p>
</caption>
<graphic xlink:href="fmolb-10-1096261-g006.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 Recombinant purification of acetylated human selenoprotein GPx1</title>
<p>To prove the versatility and utility of our system, we produced an authentic selenoprotein, human GPx1. GPx1 is predicted to be acetylated at different Lys residues based on murine GPx1 MS studies (<xref ref-type="bibr" rid="B23">Rardin et al., 2013</xref>). We individually targeted K114 and K148 together with the Sec at position 49. The protein was expressed under the same conditions with the same plasmid backbone as described for sfGFP (<xref ref-type="fig" rid="F7">Figure 7A</xref>). Three bands were visible on the polyacrylamide gel, with the lower band corresponding to the expected size of monomeric GPx1 (25&#xa0;kDa). In terms of protein yield, we found that GPx1_148AcK had roughly twice as much protein as GPx1_114AcK. This may be a result of codon context or the closer proximity of position 114 to 49Sec (<xref ref-type="fig" rid="F7">Figure 7B</xref>). To confirm incorporation of AcK, a western blot with an anti-AcK antibody was used (<xref ref-type="fig" rid="F7">Figure 7B</xref>). The western blot revealed the presence of acetylation in the higher molecular weight band which is approximately 30%&#x2013;35% of the total protein (<xref ref-type="sec" rid="s10">Supplementary Figure S3</xref>). We surmise that the lower molecular weight band corresponds to a GPx1 variant containing Gln (65%&#x2013;70%) instead of AcK as suggested by the sfGFP MS data. This provides evidence that imply the potential role of AcK in GPx1 oligomerization, and emphasizes the necessity for a system which can study post-translationally modified selenoproteins.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Production of post-translationally modified human GPx1. <bold>(A)</bold> Plasmids used for insertion of selenocysteine and <italic>N</italic>
<sub>&#x3b5;</sub>-acetyl-<sc>l</sc>-lysine (AcK) into GPx1 at UGA and UAG, respectively. Two variants were made with AcK at either position 114 or 148. <bold>(B)</bold> 4%&#x2013;20% PAGE shows three bands on the gel for each variant, with the strongest one at the 25-kDa marker corresponding to monomeric GPx1 (24&#xa0;kDa). An increase in protein yield was observed for 148AcK. Western blot with anti-AcK antibody targeted the two higher molecular weight bands.</p>
</caption>
<graphic xlink:href="fmolb-10-1096261-g007.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>Here we established a method for the simultaneous incorporation of selenocysteine and the ncAA <italic>N</italic>
<sub>&#x3b5;</sub>-acetyl-<sc>l</sc>-lysine into a protein at two targeted positions in <italic>E</italic>. <italic>coli</italic>. This method integrates pSec_Evol and MaPylRS:tRNA<sup>Pyl</sup> non-sense translation systems for the first time (<xref ref-type="fig" rid="F1">Figure 1</xref>). This was accomplished by characterizing the decoding efficiency, specificity, and compatibility of these systems. We found that allo-tRNA<sup>UTu1D</sup> and <italic>Ma</italic>AcLysRS3:tRNA<sup>Pyl</sup> are compatible when UGA and UAG are assigned to Sec and AcK, respectively (<xref ref-type="fig" rid="F3">Figures 3B, C</xref>). In contrast, allo-tRNA<sup>UTu1D</sup>
<sub>CUA</sub> and tRNA<sup>Pyl</sup>
<sub>UCA</sub> lacked decoding fidelity as they translated both UGA and UAG codons, albeit with different efficiencies (<xref ref-type="fig" rid="F2">Figures 2B, C</xref>). Thus, our results indicate that the codon specificity of these two translation systems should be an essential consideration when developing GCE applications, particularly when combining them with other systems. Another important consideration is the position of the non-sense codons within each protein as mRNA context can influence the suppressor tRNAs as well as the proximity of the two ncAAs. The off-target activity of these tRNAs with non-specific anticodons may hinder the accurate incorporation of the desired amino acid and drastically decrease protein yields by impacting the fitness of the host organism. Using this knowledge, we demonstrated that pSecUGA and <italic>Ma</italic>AcLysRS3:tRNA<sup>Pyl</sup>
<sub>CUA</sub> systems could be combined in <italic>E</italic>. <italic>coli</italic> to create a platform for synthesizing proteins containing these two important amino acids. This provides the groundwork to produce acetylated natural or synthetic selenoproteins. The utility of our method can be expanded by combining the pSecUGA system with other existing GCE platforms to facilitate the synthesis of selenoproteins containing other important PTMs or ncAAs with reactive side chains to expand protein functionalization (<xref ref-type="bibr" rid="B33">Young and Schultz, 2018</xref>; <xref ref-type="bibr" rid="B25">Shandell et al., 2021</xref>). Ultimately, this technology can enable the investigation of PTMs in naturally occurring selenoproteins and the development of artificial proteins endowed with unique chemical properties.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>PM and NK performed the cloning and fluorescence assays. CC, LN, and NK performed protein expression and purification. PM, NK, and OV-R wrote the manuscript. OV-R, CZC, and NK conceptualized the experiments and edited the manuscript. DS and PH edited the manuscript and supported the research.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This work was supported by grants from the National Institute of General Medical Sciences (R35GM122560-05S1 to DS) and the National Institute of Allergy and Infectious Diseases (5R01AI147496 to PH). Genetic experiments were supported by the Department of Energy Office of Basic Energy Sciences (DE-FG0298ER2031 to DS). CZC holds a Postdoctoral Fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC).</p>
</sec>
<ack>
<p>We are grateful to Kyle Hoffman (Bioinformatics Solutions Inc.) for intellectual and technical assistance with the mass spectrometry analyses. We also thank the Keck Oligo Synthesis Resource at Yale for assisting with nucleotide synthesis services and Kexin Meng for experimental advice and support.</p>
</ack>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2023.1096261/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmolb.2023.1096261/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.PDF" id="SM1" mimetype="application/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aldag</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Br&#xf6;cker</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Hohn</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Prat</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hammond</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Plummer</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Rewiring translation for elongation factor Tu-dependent selenocysteine incorporation</article-title>. <source>Angew. Chem. Int. Ed. Engl.</source> <volume>52</volume> (<issue>5</issue>), <fpage>1441</fpage>&#x2013;<lpage>1445</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201207567</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Appleby-Tagoe</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Thiel</surname>
<given-names>I. V.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mootz</surname>
<given-names>H. D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X. Q.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Highly efficient and more general cis- and trans-splicing inteins through sequential directed evolution</article-title>. <source>J. Biol. Chem.</source> <volume>286</volume> (<issue>39</issue>), <fpage>34440</fpage>&#x2013;<lpage>34447</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.277350</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balasuriya</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Davey</surname>
<given-names>N. E.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Biggar</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Cantley</surname>
<given-names>L. C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Phosphorylation-dependent substrate selectivity of protein kinase B (AKT1)</article-title>. <source>J. Biol. Chem.</source> <volume>295</volume> (<issue>24</issue>), <fpage>8120</fpage>&#x2013;<lpage>8134</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.RA119.012425</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chatterjee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Furman</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>P. G.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>A versatile platform for single- and multiple-unnatural amino acid mutagenesis in <italic>Escherichia coli</italic>
</article-title>. <source>Biochemistry</source> <volume>52</volume> (<issue>10</issue>), <fpage>1828</fpage>&#x2013;<lpage>1837</lpage>. <pub-id pub-id-type="doi">10.1021/bi4000244</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Venkat</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McGuire</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Recent development of genetic code expansion for posttranslational modification studies</article-title>. <source>Molecules</source> <volume>23</volume> (<issue>7</issue>), <fpage>1662</fpage>. <pub-id pub-id-type="doi">10.3390/molecules23071662</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname>
<given-names>C. Z.</given-names>
</name>
<name>
<surname>Krahn</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The selenocysteine toolbox: A guide to studying the 21st amino acid</article-title>. <source>Arch. Biochem. Biophys.</source> <volume>730</volume>, <fpage>109421</fpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2022.109421</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname>
<given-names>C. Z.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>S&#xf6;ll</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Krahn</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Introducing selenocysteine into recombinant proteins in <italic>Escherichia coli</italic>
</article-title>. <source>Curr. Protoc.</source> <volume>1</volume> (<issue>2</issue>), <fpage>e54</fpage>. <pub-id pub-id-type="doi">10.1002/cpz1.54</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname>
<given-names>C. Z.</given-names>
</name>
<name>
<surname>Krahn</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Crnkovi&#x107;</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>S&#xf6;ll</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Intein-based design expands diversity of selenocysteine reporters</article-title>. <source>J. Mol. Biol.</source> <volume>434</volume> (<issue>8</issue>), <fpage>167199</fpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2021.167199</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Copeland</surname>
<given-names>P. R.</given-names>
</name>
<name>
<surname>Fletcher</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Hatfield</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Driscoll</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs</article-title>. <source>EMBO J.</source> <volume>19</volume> (<issue>2</issue>), <fpage>306</fpage>&#x2013;<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/19.2.306</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crnkovi&#x107;</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>S&#xf6;ll</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>N. M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Pyrrolysyl-tRNA synthetase, an aminoacyl-tRNA synthetase for genetic code expansion</article-title>. <source>Croat. Chem. Acta</source> <volume>89</volume> (<issue>2</issue>), <fpage>163</fpage>&#x2013;<lpage>174</lpage>. <pub-id pub-id-type="doi">10.5562/cca2825</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dunkelmann</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Willis</surname>
<given-names>J. C. W.</given-names>
</name>
<name>
<surname>Beattie</surname>
<given-names>A. T.</given-names>
</name>
<name>
<surname>Chin</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Engineered triply orthogonal pyrrolysyl-tRNA synthetase/tRNA pairs enable the genetic encoding of three distinct non-canonical amino acids</article-title>. <source>Nat. Chem.</source> <volume>12</volume> (<issue>6</issue>), <fpage>535</fpage>&#x2013;<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1038/s41557-020-0472-x</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hilal</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Killam</surname>
<given-names>B. Y.</given-names>
</name>
<name>
<surname>Grozdanovi&#x107;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dobosz-Bartoszek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Loerke</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Burger</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Structure of the mammalian ribosome as it decodes the selenocysteine UGA codon</article-title>. <source>Science</source> <volume>376</volume> (<issue>6599</issue>), <fpage>1338</fpage>&#x2013;<lpage>1343</lpage>. <pub-id pub-id-type="doi">10.1126/science.abg3875</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kossinova</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Malygin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Krol</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Karpova</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The SBP2 protein central to selenoprotein synthesis contacts the human ribosome at expansion segment 7L of the 28S rRNA</article-title>. <source>RNA</source> <volume>20</volume> (<issue>7</issue>), <fpage>1046</fpage>&#x2013;<lpage>1056</lpage>. <pub-id pub-id-type="doi">10.1261/rna.044917.114</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lacoursiere</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>O&#x27;Donoghue</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>G. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Programmed ubiquitin acetylation using genetic code expansion reveals altered ubiquitination patterns</article-title>. <source>FEBS Lett.</source> <volume>594</volume> (<issue>7</issue>), <fpage>1226</fpage>&#x2013;<lpage>1234</lpage>. <pub-id pub-id-type="doi">10.1002/1873-3468.13702</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hoshi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ohtake</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Highly reproductive <italic>Escherichia coli</italic> cells with no specific assignment to the UAG codon</article-title>. <source>Sci. Rep.</source> <volume>5</volume>, <fpage>9699</fpage>. <pub-id pub-id-type="doi">10.1038/srep09699</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Vargas-Rodriguez</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Englert</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tripp</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Ivanova</surname>
<given-names>N. N.</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>E. M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Transfer RNAs with novel cloverleaf structures</article-title>. <source>Nucleic Acids Res.</source> <volume>45</volume> (<issue>5</issue>), <fpage>2776</fpage>&#x2013;<lpage>2785</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw898</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sevostyanova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>S&#xf6;ll</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>A facile method for producing selenocysteine-containing proteins</article-title>. <source>Angew. Chem. Int. Ed. Engl.</source> <volume>57</volume> (<issue>24</issue>), <fpage>7215</fpage>&#x2013;<lpage>7219</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201713215</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neumann</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Slusarczyk</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Chin</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>De novo generation of mutually orthogonal aminoacyl-tRNA synthetase/tRNA pairs</article-title>. <source>J. Am. Chem. Soc.</source> <volume>132</volume> (<issue>7</issue>), <fpage>2142</fpage>&#x2013;<lpage>2144</lpage>. <pub-id pub-id-type="doi">10.1021/ja9068722</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Novoselov</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Lobanov</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kasaikina</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Hatfield</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Gladyshev</surname>
<given-names>V. N.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>A highly efficient form of the selenocysteine insertion sequence element in protozoan parasites and its use in mammalian cells</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>104</volume> (<issue>19</issue>), <fpage>7857</fpage>&#x2013;<lpage>7862</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0610683104</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Pinkerton</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Copeland</surname>
<given-names>P. R.</given-names>
</name>
</person-group> (<year>2016</year>). &#x201c;<article-title>Eukaryotic mechanisms of selenocysteine incorporation and its reconstitution <italic>in vitro</italic>
</article-title>,&#x201d; in <source>Selenium: its molecular biology and role in human health</source>. <edition>Fourth ed</edition> (<publisher-name>Springer International Publishing</publisher-name>), <fpage>13</fpage>&#x2013;<lpage>24</lpage>.</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Porter</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Mehl</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Genetic code expansion: A powerful tool for understanding the physiological consequences of oxidative stress protein modifications</article-title>. <source>Oxid. Med. Cell Longev.</source> <volume>2018</volume>, <fpage>7607463</fpage>. <pub-id pub-id-type="doi">10.1155/2018/7607463</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prabhakar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Krahn</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vargas-Rodriguez</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Krupkin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Uncovering translation roadblocks during the development of a synthetic tRNA</article-title>. <source>Nucleic Acids Res.</source> <volume>50</volume> (<issue>18</issue>), <fpage>10201</fpage>&#x2013;<lpage>10211</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkac576</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rardin</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Newman</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Held</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Cusack</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Sorensen</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>110</volume> (<issue>16</issue>), <fpage>6601</fpage>&#x2013;<lpage>6606</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1302961110</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seki</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yanagisawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kuratani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sakamoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Fully productive cell-free genetic code expansion by structure-based engineering of <italic>Methanomethylophilus alvus</italic> pyrrolysyl-tRNA synthetase</article-title>. <source>ACS Synth. Biol.</source> <volume>9</volume> (<issue>4</issue>), <fpage>718</fpage>&#x2013;<lpage>732</lpage>. <pub-id pub-id-type="doi">10.1021/acssynbio.9b00288</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shandell</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cornish</surname>
<given-names>V. W.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Genetic code expansion: A brief history and perspective</article-title>. <source>Biochemistry</source> <volume>60</volume> (<issue>46</issue>), <fpage>3455</fpage>&#x2013;<lpage>3469</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biochem.1c00286</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tharp</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Ad</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Amikura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>F. R.</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Cate</surname>
<given-names>J. H. D.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Initiation of protein synthesis with non-canonical amino acids <italic>in vivo</italic>
</article-title>. <source>Angew. Chem. Int. Ed. Engl.</source> <volume>59</volume> (<issue>8</issue>), <fpage>3122</fpage>&#x2013;<lpage>3126</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201914671</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tharp</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Vargas-Rodriguez</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Schepartz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>S&#xf6;ll</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Genetic encoding of three distinct noncanonical amino acids using reprogrammed initiator and nonsense codons</article-title>. <source>ACS Chem. Biol.</source> <volume>16</volume> (<issue>4</issue>), <fpage>766</fpage>&#x2013;<lpage>774</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.1c00120</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Venkat</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sturges</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Stahman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gregory</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Genetically incorporating two distinct post-translational modifications into one protein simultaneously</article-title>. <source>ACS Synth. Biol.</source> <volume>7</volume> (<issue>2</issue>), <fpage>689</fpage>&#x2013;<lpage>695</lpage>. <pub-id pub-id-type="doi">10.1021/acssynbio.7b00408</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sachdeva</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Wilf</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Optimized orthogonal translation of unnatural amino acids enables spontaneous protein double-labelling and FRET</article-title>. <source>Nat. Chem.</source> <volume>6</volume> (<issue>5</issue>), <fpage>393</fpage>&#x2013;<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1038/nchem.1919</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wright</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Altaany</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Alperstein</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>O&#x27;Donoghue</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Acetylation regulates thioredoxin reductase oligomerization and activity</article-title>. <source>Antioxid. Redox Signal</source> <volume>29</volume> (<issue>4</issue>), <fpage>377</fpage>&#x2013;<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2017.7082</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>H. S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Chemical biology approaches for studying posttranslational modifications</article-title>. <source>RNA Biol.</source> <volume>15</volume> (<issue>4-5</issue>), <fpage>427</fpage>&#x2013;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1080/15476286.2017.1360468</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The role and mechanism of essential selenoproteins for homeostasis</article-title>. <source>Antioxidants (Basel)</source> <volume>11</volume> (<issue>5</issue>), <fpage>973</fpage>. <pub-id pub-id-type="doi">10.3390/antiox11050973</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>P. G.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Playing with the molecules of life</article-title>. <source>ACS Chem. Biol.</source> <volume>13</volume> (<issue>4</issue>), <fpage>854</fpage>&#x2013;<lpage>870</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.7b00974</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>